Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

85.48

-0.60 (-0.70%)

At close: Feb 20, 2026, 4:00 PM EST

83.50

-1.98 (-2.32%)

After-hours: Feb 20, 2026, 7:32 PM EST

Bright Minds Biosciences Employees

Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

2,500.00%

Revenue / Employee

n/a

Profits / Employee

-$556,655

Market Cap

843.56M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Sep 30, 2025	26	25	2,500.00%
Sep 30, 2024	1	-	-

Related Stocks

Company Name	Employees
Maravai LifeSciences Holdings	550
Arvinas	430
KalVista Pharmaceuticals	270
Xencor	250
Omeros	202
Cullinan Therapeutics	111
Janux Therapeutics	109
Arbutus Biopharma	44

Employee Rankings

DRUG News

6 weeks ago - Bright Minds Biosciences Announces Closing of US$175 Million Public Offering - GlobeNewsWire
6 weeks ago - Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock - GlobeNewsWire
6 weeks ago - Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating - Seeking Alpha
6 weeks ago - Bright Minds Biosciences Announces Launch of US$100 Million Public Offering - GlobeNewsWire
6 weeks ago - New Bright Minds Epilepsy Drug Cuts Seizures, Lifts Stock On Tuesday - Benzinga
6 weeks ago - Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE) - GlobeNewsWire
6 weeks ago - Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026 - GlobeNewsWire
3 months ago - Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting - GlobeNewsWire

More News